Echolight obtains ISO environmental certification, our contribution to a sustainable future

In August 2022, Echolight S.P.A. has also achieved the prestigious ISO 14001 Environmental Certification of its management system. Specifically, the Notified Body in charge, Kiwa Cermet in our case, states that the design, production and marketing of Echolight ultrasound software medical diagnostic devices complies with the UNI EN ISO 14001: 2015 standard. This non-compulsory but voluntary certification confirms the company’s intention to have a management system capable of keeping under control and minimizing or, where possible, cancelling any environmental impact linked to its activities, seeking an improvement in an effective and above all sustainable way, applying the Plan-Do-Check-Act cycle, «Plan-Do-Check-Act».

“We are proud to have also reached this milestone which confirms our sensitivity to the environment in which we live and which makes us particularly happy given the emerging global environmental crisis and to which we want to contribute in our small way. In fact, Echolight aims not only to improve people’s lives by developing new technologies in the medical field, but by making use of business processes with low or no environmental impact, putting respect for the environment first as well as the health of people.” – says the CEO of Echolight S.P.A. Eng. Sergio Casciaro.

EULAR 2022

EULAR 2022

New scientific studies presented at the recent European Congress of Rheumatology EULAR 2022:   Radiofrequency Echographic Multi Spectrometry (REMS) for the assessment of femoral bone health in a male population Fiorella Anna Lombardi1, Paola Pisani1, Alessandra...

read more
Anorexia and bone density

Anorexia and bone density

Assessment of bone mineral density in young women with anorexia nervosa by means of Radiofrequency Echographic Multispectrometry (REMS) technology. Caffarelli1, M. D. Tomai Pitinca1, A. Al Refaie1, M. De Vita1, E. Giglio1, P. Pisani2, S. Gonnelli1   1Dept. of...

read more
Kidney transplant patients

Kidney transplant patients

Radiofrequency Echographic Multi Spectrometry (REMS) technology and DXA for BMD assessment in kidney transplant recipients Fassio 1, S. Andreola2, D. Gatti1, M. Gatti1, G. Gambaro2, M. Rossini 1, P. Pisani 3, F. A. Lombardi 3, G. Adami1 1 Rheumatology Unit, University...

read more

    Contact Us

    More info or book a demo.



    Position*

    *Required fields



    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Echolight S.p.a.

    Viale Cipro, 6
    73100 Lecce – Italy
    +39 0832 159 26 07

    US Headquarters
    509 Madison Ave RM 1510
    New York, New York 10022, USA
    +1-833-263-7367
    +1 425 658 0601

    Copyright © 2021 - Echolight S.p.a